Altimmune (ALT) Research & Development (2010 - 2026)
Altimmune (ALT) posted Research & Development of $18.66 million for Q2 2026, up 8.2% from $17.24 million a year earlier and up 15.2% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Altimmune was $68.22 million, down 6.1% year-over-year; for FY2025, it came in at $66.43 million, down 19.2% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
- In prior years, Altimmune's Research & Development was $82.23 million in FY2024 (+25.0%), $65.8 million in FY2023 (-6.7%), $70.54 million in FY2022 (-5.4%) and $74.54 million in FY2021 (+49.8%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development increased in four of the last eight quarters, with an average decline of 5.1%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 125.5%; the weakest was Q3 2022, with a decline of 30.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $16.19 million (Q1 2026), $18.41 million (Q4 2025) and $14.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | 18.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.66 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 14.96 Mn |
| Jun 30, 2025 | 17.24 Mn |
| Mar 31, 2025 | 15.83 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 19.80 Mn |
| Jun 30, 2024 | 21.16 Mn |
| Mar 31, 2024 | 21.49 Mn |
| Dec 31, 2023 | 16.91 Mn |
| Sep 30, 2023 | 18.39 Mn |
| Jun 30, 2023 | 13.25 Mn |
| Mar 31, 2023 | 17.25 Mn |
| Dec 31, 2022 | 19.18 Mn |
| Sep 30, 2022 | 20.26 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 15.10 Mn |
| Dec 31, 2021 | 20.19 Mn |
| Sep 30, 2021 | 29.21 Mn |
API Access
Altimmune Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();